Natural gas drops 10%, pulls back from more than 13-year high

Natural gas drops 10%, pulls back from more than 13-year high


U.S. natural gas futures plunged more than 10% Tuesday, reversing Monday’s surge which saw the contract rally more than 10% at one point to break above $8 per million British thermal units and hit the highest level since September 2008.

Henry Hub prices declined 10.2% Tuesday to trade at $7.02. The May contract is now down roughly 13% from Monday’s high.

Natural gas prices have been on a tear since Russia’s invasion of Ukraine in late February. The contract is coming off five straight weeks of gains and is up nearly 90% for the year.

Matt Maley, chief market strategist at Miller Tabak, said Monday that natural gas looked ripe for a pullback from a technical perspective. Pointing to the relative strength index, a momentum indicator, Maley said the commodity was second-most overbought since 2003.

“Its RSI chart is now up to levels that have been followed by short-term pullbacks in the past,” he noted Thursday. “We are still bullish on natural gas (and natural gas-related stocks), so we’re not saying that investors should take profits right here. Instead, we [are] merely saying that investors should avoid chasing these assets over the near term.”

Prices surged Monday on forecasts for colder spring temperatures, fuel switching from coal to natural gas, as well as the U.S. sending record amounts of LNG to Europe.



Source

Inside the booming business of wellness third spaces and membership clubs
Business

Inside the booming business of wellness third spaces and membership clubs

A few years ago, Grace Guo began to crave places in New York City where hanging out with friends didn’t have to involve alcohol. Newly sober and surrounded by friends who also chose not to drink, Guo said she wanted alternatives to the typical social scene. After some research, she landed on Bathhouse and Othership: […]

Read More
FDA vaccine head will step down in April after string of controversial decisions
Business

FDA vaccine head will step down in April after string of controversial decisions

The logo for the Food and Drug Administration is seen ahead of a news conference at the Health and Human Services Headquarters in Washington, DC on April 22, 2025. Nathan Posner | Anadolu | Getty Images A key U.S. Food and Drug Administration official who oversees vaccines and biotech treatments will step down from the […]

Read More
FDA reversals leave investors worrying about the fates of other experimental drugs
Business

FDA reversals leave investors worrying about the fates of other experimental drugs

Investors are concerned about the fates of multiple experimental drugs for hard-to-treat diseases following a string of recent rejections from the U.S. Food and Drug Administration.  The FDA in the past year has denied or discouraged the applications of at least eight drugs, according to RTW Investments, including a gene therapy for Huntington’s disease from […]

Read More